Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1,459 INR | -1.33% | -2.39% | +15.87% |
May. 27 | Indian drugmakers to see FY25 revenue boost in key US market, says India Ratings and Research | RE |
May. 25 | Sun Pharma to Pursue M&A | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+15.87% | 42.57B | |
+17.49% | 21.01B | |
+16.67% | 14.86B | |
+18.52% | 14.47B | |
+50.48% | 12.61B | |
-0.05% | 6.79B | |
-12.40% | 6.57B | |
-8.87% | 5.73B | |
+14.28% | 5.62B | |
+6.11% | 4.66B |
- Stock Market
- Equities
- SUNPHARMA Stock
- News Sun Pharmaceutical Industries Ltd.
- Nomura Adjusts Sun Pharmaceutical Industries' Price Target to INR1,132 From INR1,190, Keeps at Buy